Valion Bio (VBIO) Price to Book (2021 - 2026)

Valion Bio has reported Price to Book for 6 years, with the latest figure at 0.02 in Q2 2026.

• On a quarterly basis, Price to Book fell 61.93% year-over-year to 0.02 in Q2 2026; TTM through Jun 2026 was 0.02, a 61.93% decrease from a year earlier, with the FY2025 full-year figure at 0.0, down 85.05% from the prior year.
• Price to Book was 0.02 for Q2 2026 at Valion Bio, up from 0.0 in the prior quarter.
• The five-year high for Price to Book was 155.83 in Q2 2022, with the low at 0.0 in Q4 2025.
• Average Price to Book over 5 years is 15.15, with a median of 0.27 recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Price to Book sank 99.59% in 2023, then surged 54.0% in 2024.
• Over 5 years, Price to Book stood at 1.16 in 2022, then slumped by 76.63% to 0.27 in 2023, then plunged by 90.16% to 0.03 in 2024, then slumped by 85.05% to 0.0 in 2025, then surged by 314.98% to 0.02 in 2026.
• The last three Price to Book figures came in at 0.02 (Q2 2026), 0.0 (Q4 2025), and 0.04 (Q3 2025), per Business Quant data.